Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-04

Clinical Trial Update: Hydrocortisone and Fludrocortisone for the Treatment of Septic Shock [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the combination of hydrocortisone and fludrocortisone for septic shock is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fludrocortisone (Fludrocortisone)
  • HYDROCORTISONE (HYDROCORTISONE)

Snippet

Sponsor: Northern Jiangsu People's Hospital | Conditions: Septic Shock | Phase 4 | Status: RECRUITING